RenovoRx (RNXT) Shares Outstanding (2020 - 2026)

RenovoRx has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $45.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 23.27% year-over-year to $45.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.1 million (up 23.27% YoY) and the FY2025 annual result came in at $36.6 million, up 52.34% from the prior year.
• Shares Outstanding (Entity) climbed to $45.1 million in Q1 2026 per RNXT's latest filing, from $36.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $45.1 million in Q1 2026 and troughed at $9.0 million in Q1 2022.
• A 5-year average of $21.1 million and a median of $16.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) soared 302.78% in 2022, then gained 1.13% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $9.1 million in 2022, then advanced by 17.54% to $10.7 million in 2023, then soared by 124.76% to $24.0 million in 2024, then soared by 52.34% to $36.6 million in 2025, then advanced by 23.05% to $45.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $45.1 million, $36.6 million, and $36.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.